who makes tirzepatide Eli Lilly launches weight-loss drug Mounjaro in India, beats Novo Nordisk to major market Tirzepatide (Zepbound) for weight loss

Provide access to obesity experts and tailored treatment

The pharmaceutical giant announced results from two distinct trials on Thursday

Recommended Next Reads Build a stronger tracking plan with our best GLP-1 app guide, GLP-1 tracker app overview, semaglutide guide, and tirzepatide guide

Eli Lilly & Company (US) Founded in 1876, Eli Lilly is a key innovator in metabolic health, contributing significantly to the evolution of GLP-1 receptor agonists and incretin-based therapies

Need for ongoing monitoring : Since its a new drug, patients may need more frequent monitoring by providers to ensure safety and efficacy which can be inconvenient

Increased energy and better overall well-being